Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies.

[1]  M. Vilaseca,et al.  Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia. , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[2]  R. Artuch,et al.  Homocysteine and other plasma amino acids in preeclampsia and in pregnancies without complications. , 2003, Clinical biochemistry.

[3]  M. Dunbar,et al.  The 677 C‐T Methylenetetrahydrofolate Reductase Mutation Does Not Predict Increased Maternal Homocysteine During Pregnancy , 2003, Obstetrics and gynecology.

[4]  M. McDonnell,et al.  Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. , 2002, American journal of human genetics.

[5]  R. Fimmers,et al.  The Methylenetetrahydrofolate Reductase 677 C→T Polymorphism and Preeclampsia in Two Populations , 2002, Obstetrics and gynecology.

[6]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[7]  J. Murray,et al.  Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. , 2001, American journal of obstetrics and gynecology.

[8]  E. Steegers,et al.  Hyperhomocysteinaemia: a risk factor for preeclampsia? , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[9]  G. Pals,et al.  Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. , 2001, American journal of obstetrics and gynecology.

[10]  J. Ordovás,et al.  Homocysteine and the MTHFR 677C→T allele in premature coronary artery disease. Case control and family studies , 2001, European journal of clinical investigation.

[11]  F. Yang,et al.  Influence of 699C→T and 1080C→T polymorphisms of the cystathionine β‐synthase gene on plasma homocysteine levels , 2000, Clinical genetics.

[12]  S. Brennecke,et al.  C677T Methylenetetrahydrofolate Reductase Polymorphism Is Not a Risk Factor for Pre-Eclampsia/Eclampsia among Australian Women , 2000, Human Heredity.

[13]  M. Vilaseca,et al.  Homocisteína y gestación , 2000 .

[14]  K. Kontula,et al.  677 C→T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and Preeclampsia , 2000, Obstetrics and gynecology.

[15]  Quanhe Yang,et al.  5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.

[16]  H. Blom,et al.  A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. , 2000, American journal of obstetrics and gynecology.

[17]  S. Vollset,et al.  Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. , 2000, The American journal of clinical nutrition.

[18]  M. Tsai,et al.  Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. , 2000, Atherosclerosis.

[19]  S. Scherer,et al.  Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. , 1999, Gene.

[20]  R. Rozen,et al.  A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. , 1999, Molecular genetics and metabolism.

[21]  D. Luthy,et al.  Elevated Second-Trimester Serum Homocyst(e)ine Levels and Subsequent Risk of Preeclampsia , 1999, Gynecologic and Obstetric Investigation.

[22]  Graeme N. Smith,et al.  Changes in homocysteine levels during normal pregnancy. , 1999, American journal of obstetrics and gynecology.

[23]  R. Ness,et al.  Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. , 1999 .

[24]  M. Miodovnik,et al.  Prediction of preeclampsia. , 1999, Seminars in perinatology.

[25]  R. Ness,et al.  Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. , 1998, American journal of obstetrics and gynecology.

[26]  W. Ansorge,et al.  The human cystathionine beta-synthase (CBS) gene: complete sequence, alternative splicing, and polymorphisms. , 1998, Genomics.

[27]  J. D. Vries,et al.  Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. , 1998, American journal of obstetrics and gynecology.

[28]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[29]  H. Blom,et al.  Genetic risk factor for unexplained recurrent early pregnancy loss , 1997, The Lancet.

[30]  A. Rajkovic,et al.  Elevated Homocyst(e)ine Levels With Preeclampsia , 1997, Obstetrics and gynecology.

[31]  T. Arinami,et al.  Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. , 1997, Journal of medical genetics.

[32]  D Paladini,et al.  Factor V Leiden, C>T MTHFR Polymorphism and Genetic Susceptibility to Preeclampsia , 1997, Thrombosis and Haemostasis.

[33]  P. Goyette,et al.  Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. , 1996, Human molecular genetics.

[34]  M. Stanton,et al.  Homocysteine and cardiovascular disease , 2011 .

[35]  M. P. Sperandeo,et al.  The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. , 1995, American journal of human genetics.

[36]  S. S. Kang,et al.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. , 1988, American journal of human genetics.

[37]  P. Taylor,et al.  J Soc Gynecol Investig , 2005 .

[38]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.